Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
NEW YORK , Oct. 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Snap Inc. (NYSE: SNAP) between April 29, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), both dates inclusive, of the important October 20, 2025 lead plaintiff deadline. So what: If you purchased Snap securities during the Class Period you may...
LOS ANGELES , Oct. 14, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Snap Inc. ("Snap" or the "Company") (NYSE: SNAP) have opportunity to lead the securities fraud class action lawsuit.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Snap (SNAP) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Snap between April 29, 2025, to August 5, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-...
LOS ANGELES , Oct. 10, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Snap Inc. ("Snap" or the "Company") (NYSE: SNAP). IF YOU SUFFERED A LOSS ON YOUR SNAP INVESTMENTS, CLICK HERE BEFORE OCTOBER 20, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What I...
The complaint alleges Snap misled investors about ad growth, hiding that revenue fell from 9% in Q1 to 1% in April because of internal execution failures.
The European Commission is scrutinising safeguards for minors on Snapchat, YouTube, the Apple App Store and Google Play under its Digital Services Act, it said on Friday.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.